HER-2 POSITIVE MALIGNANT CARCINOMA OF BREAST

Clinical trials for HER-2 POSITIVE MALIGNANT CARCINOMA OF BREAST explained in plain language.

Never miss a new study

Get alerted when new HER-2 POSITIVE MALIGNANT CARCINOMA OF BREAST trials appear

Sign up with your email to follow new studies for HER-2 POSITIVE MALIGNANT CARCINOMA OF BREAST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New imaging agent aims to spot HER2 cancers more clearly

Diagnosis Ongoing

This study tests whether a new imaging drug called 89Zr-ss-pertuzumab is safe for people with HER2-positive breast or other cancers. About 60 participants will receive the drug and be monitored for side effects. The goal is to improve how doctors see these cancers on scans, not t…

Matched conditions: HER-2 POSITIVE MALIGNANT CARCINOMA OF BREAST

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis

Last updated Apr 30, 2026 15:49 UTC

HER-2 POSITIVE MALIGNANT CARCINOMA OF BREAST

Get alerted when new HER-2 POSITIVE MALIGNANT CARCINOMA OF BREAST trials appear

New imaging agent aims to spot HER2 cancers more clearly